November 5th, 2018
BioVersys hires new CFO
BioVersys strengthens its executive management team with the arrival of Matthias Werder as Chief...
September 20, 2018
September 19th, 2018
September 18th, 2018
Recent Media Feeds
- BioVersys Receives QIDP Designation from the U.S. FDA for the Development of BV100
- Press Release - BioVersys hires new CDO, Dr. Glenn Dale
- Eurostars Funds IMPACT2 Press Release
- Press Release - New CFO at BioVersys - Matthias Werder
- Dr. Gitzinger will be speaking at the UNCTAD/WHO event in Geneva, October 23rd, 2018 from 14:30-17:30 on Fostering investment in the development of new antibacterial treatments
- CARB-X welcomes UK Government and Bill & Melinda Gates Foundation as new partners
- BioVersys successfully closes Series A2 financing round
- World Antibiotic Awareness Week - November 13-19th, 2017
- October 20th, 2017; BioVersys and Marc Gitzinger were featured in the 3Sat news.
- BEAM Alliance fordert G20 Staaten zu mehr Unterstützung im Kampf gegen tödliche Superkeime auf
- Swiss biopharma BioVersys is collaborating with drug discovery and development CRO Aptuit on the discovery and development of new targets and drug candidates against Gram-negative bacteria, including drug-resistant strains. An existing BioVersys target will be included in the partnership.
- Press Release BEAM Alliance / Biocom AG
- Breaking through the Wall ... A Call for Concerted Action on AB Research and Development
- Fighting AMR efficiently
- Beam Alliance appoints Marc Gitzinger as VP on the Board of Directors